ACUTE LYMPHOBLASTIC LEUKEMIA
Clinical trials for ACUTE LYMPHOBLASTIC LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new ACUTE LYMPHOBLASTIC LEUKEMIA trials appear
Sign up with your email to follow new studies for ACUTE LYMPHOBLASTIC LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New protocol aims to boost survival in adult leukemia patients
Disease control Not yet recruitingThis study tests a new treatment plan for adults up to 65 years old with a type of leukemia called Ph-negative acute lymphoblastic leukemia. The goal is to see if adding an immunotherapy drug called blinatumomab improves survival compared to the previous treatment plan. About 330…
Matched conditions: ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: NA • Sponsor: PETHEMA Foundation • Aim: Disease control
Last updated May 26, 2026 03:25 UTC
-
Promising new combo therapy targets leukemia in young patients
Disease control Not yet recruitingThis study tests a new combination of chemotherapy and immunotherapy drugs for adolescents and young adults (ages 15-39) with newly diagnosed Philadelphia chromosome-negative acute lymphoblastic leukemia (ALL). The goal is to see if this treatment plan helps more patients complet…
Matched conditions: ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: PHASE2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated May 26, 2026 03:24 UTC
-
New drug cocktail aims to stop leukemia return after transplant
Disease control Not yet recruitingThis study tests whether adding two drugs (SHR2554 and azacitidine) to standard chemotherapy before a stem cell transplant can lower the chance of leukemia coming back. It includes 160 people aged 15-60 with high-risk or relapsed acute leukemia or myelodysplastic syndromes. Parti…
Matched conditions: ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: PHASE2 • Sponsor: The First Affiliated Hospital of Soochow University • Aim: Disease control
Last updated May 26, 2026 03:24 UTC
-
New hope for kids with resistant leukemia: triple-drug combo enters trials
Disease control Not yet recruitingThis study tests a combination of three drugs (capivasertib, venetoclax, and dexamethasone) in children and young adults up to age 21 whose leukemia or lymphoma has come back or not responded to standard treatment. The goal is to find the safest dose and see how well the drugs wo…
Matched conditions: ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: PHASE1, PHASE2 • Sponsor: Princess Maxima Center for Pediatric Oncology • Aim: Disease control
Last updated May 26, 2026 03:16 UTC
-
New drug combo aims to clear hidden leukemia in hard-to-treat genetic subtype
Disease control Not yet recruitingThis study tests whether adding the experimental drug BEBT-908 to standard chemotherapy can eliminate leftover cancer cells in adults with a specific, high-risk form of acute lymphoblastic leukemia (ALL). Participants must be in remission but still have tiny amounts of disease de…
Matched conditions: ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: PHASE2 • Sponsor: Ruijin Hospital • Aim: Disease control
Last updated May 26, 2026 03:05 UTC
-
New drug cocktail before transplant shows promise for tough leukemias
Disease control Not yet recruitingThis study tests whether adding two drugs (SHR2554 and azacitidine) to standard chemotherapy before a stem cell transplant can help people with high-risk or relapsed/refractory acute leukemia or myelodysplastic syndromes (MDS). About 180 participants aged 15-60 will be randomly a…
Matched conditions: ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: PHASE2 • Sponsor: The First Affiliated Hospital of Soochow University • Aim: Disease control
Last updated May 26, 2026 02:48 UTC
-
Antibiotic shield may protect kids with leukemia from deadly fevers
Disease control Not yet recruitingThis study tests whether giving the antibiotic levofloxacin to children with acute lymphoblastic leukemia (ALL) can delay or prevent the first episode of febrile neutropenia (a dangerous fever with low white blood cells) during their initial chemotherapy. About 124 children aged …
Matched conditions: ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: PHASE4 • Sponsor: Gadjah Mada University • Aim: Disease control
Last updated May 22, 2026 13:53 UTC
-
Promising new combo targets Hard-to-Treat leukemia in kids and young adults
Disease control Not yet recruitingThis study tests a new drug called asciminib, given with chemotherapy and later with another drug (blinatumomab), for children, teens, and young adults up to age 30 who have a certain type of leukemia (Ph+ or Ph-like ALL) that has come back or not responded to treatment. The goal…
Matched conditions: ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: PHASE1, PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated May 19, 2026 12:01 UTC
-
Under-the-skin shot aims to keep leukemia from coming back
Disease control Not yet recruitingThis study tests whether giving blinatumomab as a shot under the skin can control small amounts of leftover leukemia (called measurable residual disease) in adults with B-cell acute lymphoblastic leukemia. About 40 participants will receive the drug to see if it is safe and can p…
Matched conditions: ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 19, 2026 11:46 UTC
-
Engineered immune cells take aim at Hard-to-Treat leukemia
Disease control Not yet recruitingThis early-phase trial tests a new treatment called TSLPR-CART for adults with B-cell acute lymphoblastic leukemia (B-ALL) that has come back or not responded to standard therapy. The treatment uses a patient's own immune cells, modified in a lab to recognize and attack cancer ce…
Matched conditions: ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 18, 2026 12:01 UTC
-
Texting to beat leukemia: study tests simple reminders for chemo adherence
Symptom relief Not yet recruitingThis study looks at whether text message reminders can help teens and adults (ages 15-39) with acute lymphoblastic leukemia (ALL) take their oral chemotherapy pills on time during the maintenance phase of treatment. About 38 participants will be split into two groups: one gets fr…
Matched conditions: ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: NA • Sponsor: University of Chicago • Aim: Symptom relief
Last updated May 26, 2026 03:10 UTC
-
New gene test could speed up leukemia diagnosis for kids
Knowledge-focused Not yet recruitingThis study looks at whether a new gene test called ChromoSeq® can quickly and accurately classify leukemia in 60 children and young adults (under 30). Participants give blood or bone marrow samples at diagnosis, and researchers compare the test results to standard methods. The go…
Matched conditions: ACUTE LYMPHOBLASTIC LEUKEMIA
Sponsor: Washington University School of Medicine • Aim: Knowledge-focused
Last updated May 26, 2026 03:06 UTC
-
New study aims to catch late effects in childhood cancer survivors
Knowledge-focused Not yet recruitingThis study will create a structured follow-up program for 400 children and young adults who have survived blood cancers like leukemia and lymphoma. The goal is to better track and manage long-term health problems that can appear years after treatment. Researchers will use an elec…
Matched conditions: ACUTE LYMPHOBLASTIC LEUKEMIA
Sponsor: The Children's Hospital of Zhejiang University School of Medicine • Aim: Knowledge-focused
Last updated May 22, 2026 14:05 UTC